Q2
ALB — Q2 2026 Financial Report Analysis
Albemarle's Q2 2026 sales rose 31% to $1.74 billion and adjusted EBITDA 155% to $858 million, but the revenue bridge shows price added $562 million while volume added only $28 million — a lithium-index recovery on top of a balance sheet cut from $3.1 billion to $1.8 billion of long-term debt.